Karyopharm Therapeutics Inc. (KPTI) is a publicly traded Healthcare sector company. As of May 21, 2026, KPTI trades at $7.84 with a market cap of $161.81M and a P/E ratio of -0.48. KPTI moved +6.69% today. Year to date, KPTI is +7.84%; over the trailing twelve months it is +54.80%. Its 52-week range spans $3.51 to $16.95. Analyst consensus is strong buy with an average price target of $15.83. Rallies surfaces KPTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Karyopharm Therapeutics Inc. (KPTI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KPTI moved +6.69% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $7.84 |
| Market Cap | $161.81M |
| P/E Ratio | -0.48 |
| EPS | $-16.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.95 |
| 52-Week Low | $3.51 |
| Volume | 122 |
| Avg Volume | 0 |
| Revenue (TTM) | $151.12M |
| Net Income | $-194.97M |
| Gross Margin | 0.00% |
7 analysts cover KPTI: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.83.